Corrigendum to “Leishmania infantum: Lipophosphoglycan intraspecific variation and interaction with vertebrate and invertebrate hosts” [Int J Parasitol 2011;41:333–42]

Coelho-Finamore, J.M.; Freitas, Vanessa Cabreira de; Assis, Rafael Ramiro de; Melo, Maria Norma; Novozhilova, Natalia M.; Secundino, Nágila Francinete Costa; Pimenta, Paulo; Turco, Salvatore J.; Soares, Rodrigo Pedro

doi:10.1016/j.ijpara.2011.03.001

Cited by 4 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is likely that the resulting conformational changes induce the variation of host-guest interactions and so migration of metacyclic parasites to the anterior midgut. 6 Further contributions involving glycosylation were also identified to complement this activity: L. braziliensis adds β-(1→3)-D-Glcp to the LPG, 10,11 L. infantum removes side chains, 10,12 and L. major substitutes terminal galactose residues by β-D-(1→2)-Arap ones. 13 of superficial LPG, which was also shown to be lysis-resistant, 14,15 from procyclic to metacyclic promastigote contributes to inoculation to the mammalian host.…”

Section: Lipophosphoglycan (Lpg)mentioning

confidence: 99%

Leishmania cell wall as a potent target for antiparasitic drugs. A focus on the glycoconjugates

et al. 2015

View full text Add to dashboard Cite

Although leishmaniasis has been studied for over a century, the fight against cutaneous, mucocutaneous and visceral forms of the disease remains a hot topic. This review refers to the parasitic cell wall and more particularly to the constitutive glycoconjugates. The structures of the main glycolipids and glycoproteins, which are species-dependent, are described. The focus is on the disturbance of the lipid membrane by existing drugs and possible new ones, in order to develop future therapeutic agents.

show abstract